Real-time PCR (qPCR), also known as quantitative PCR, is the gold standard for sensitive, specific detection and quantification of nucleic acid targets. Our qPCR solutions include powerful assay designs, algorithms, optimized master mixes, intuitive data analysis software for developing infectious disease panels, pharmacogenomic panels, oncology panels, and more.

The analytical validation (AV) of qPCR assays required for test implementation can, however, be a complex and time‑consuming task.

The synbio field, a key player in the bioeconomy, is taking on some of today’s biggest challenges—from developing and manufacturing sustainable materials to helping solve the climate crisis. What is some of the hottest synbio research right now and where is the industry going?

On this episode of GEN Live, John Cumbers, PhD, CEO of SynBioBeta and Shelby Newsad, PhD, Investor at the Venture Capital firm Compound, join us for a broad discussion on the state of synbio—where the field is now and where it’s heading.

The PreOmics team will introduce the PreOmics easy-to-use iST technology. This fast 3-step workflow is designed to be a great support for both those new to proteomics and experts alike. The all-in-one iST kits are compatible with a variety of starting materials, including mammalian and plant samples, different types of tissue and cells, as well as various biological fluids in label-free and chemical labeling applications.The protocols promise an incredibly fast processing time (<2.5 hours) and are easily applicable without compromising sample quality or proteomic depth. Furthermore, iST can be fully automated to further increase standardization, reproducibility, and throughput.

This GEN webinar will explore developments within Charles River’s plasmid DNA (pDNA) CDMO service offerings, including platform screening and manufacturing approaches, improved supply chain management, 100% in-house testing, and, most recently, the launch of off-the-shelf plasmid products for viral vector manufacture.